PDCD1 and hepatocellular carcinoma: However, the clinical implications of baseline LS values by SWE in patients with advanced HCC who are treated with anti-PD-1/PD-L1 or in those treated with anti-PD-1/PD-L1 in combination with an antiangiogenic regimen have not been explored.